Pulmonx Statistics

Total Valuation

Pulmonx has a market cap or net worth of $82.91 million. The enterprise value is $62.92 million.

Market Cap	82.91M
Enterprise Value	62.92M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Pulmonx has 41.25 million shares outstanding. The number of shares has increased by 3.66% in one year.

Current Share Class	41.25M
Shares Outstanding	41.25M
Shares Change (YoY)	+3.66%
Shares Change (QoQ)	+1.25%
Owned by Insiders (%)	4.39%
Owned by Institutions (%)	72.61%
Float	39.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.88
Forward PS	0.90
PB Ratio	1.38
P/TBV Ratio	1.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.94.

Current Ratio	4.86
Quick Ratio	3.97
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.72

Financial Efficiency

Return on equity (ROE) is -73.73% and return on invested capital (ROIC) is -26.84%.

Return on Equity (ROE)	-73.73%
Return on Assets (ROA)	-23.38%
Return on Invested Capital (ROIC)	-26.84%
Return on Capital Employed (ROCE)	-49.55%
Revenue Per Employee	$314,997
Profits Per Employee	-$195,027
Employee Count	291
Asset Turnover	0.60
Inventory Turnover	1.47

Taxes

In the past 12 months, Pulmonx has paid $478,000 in taxes.

Income Tax	478,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.20% in the last 52 weeks. The beta is 0.22, so Pulmonx's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-69.20%
50-Day Moving Average	1.70
200-Day Moving Average	3.34
Relative Strength Index (RSI)	59.80
Average Volume (20 Days)	1,109,418

Short Selling Information

The latest short interest is 2.04 million, so 4.94% of the outstanding shares have been sold short.

Short Interest	2.04M
Short Previous Month	2.35M
Short % of Shares Out	4.94%
Short % of Float	5.16%
Short Ratio (days to cover)	0.35

Income Statement

In the last 12 months, Pulmonx had revenue of $91.66 million and -$56.75 million in losses. Loss per share was -$1.41.

Revenue	91.66M
Gross Profit	67.19M
Operating Income	-57.18M
Pretax Income	-56.28M
Net Income	-56.75M
EBITDA	-56.06M
EBIT	-57.18M
Loss Per Share	-$1.41

Full Income Statement

Balance Sheet

The company has $76.55 million in cash and $56.56 million in debt, giving a net cash position of $19.99 million or $0.48 per share.

Cash & Cash Equivalents	76.55M
Total Debt	56.56M
Net Cash	19.99M
Net Cash Per Share	$0.48
Equity (Book Value)	60.03M
Book Value Per Share	1.46
Working Capital	88.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.02 million and capital expenditures -$550,000, giving a free cash flow of -$32.57 million.

Operating Cash Flow	-32.02M
Capital Expenditures	-550,000
Free Cash Flow	-32.57M
FCF Per Share	-$0.79

Full Cash Flow Statement

Margins

Gross margin is 73.30%, with operating and profit margins of -62.38% and -61.91%.

Gross Margin	73.30%
Operating Margin	-62.38%
Pretax Margin	-61.39%
Profit Margin	-61.91%
EBITDA Margin	-61.16%
EBIT Margin	-62.38%
FCF Margin	n/a

Dividends & Yields

Pulmonx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.66%
Shareholder Yield	-3.66%
Earnings Yield	-68.45%
FCF Yield	-39.29%

Analyst Forecast

The average price target for Pulmonx is $6.81, which is 238.81% higher than the current price. The consensus rating is "Buy".

Price Target	$6.81
Price Target Difference	238.81%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	28.34%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pulmonx has an Altman Z-Score of -3.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.62
Piotroski F-Score	3